Japanese Wako Pure Chemical Cancer Diagnostics To Reach ¥10 Billion In Five Years
This article was originally published in PharmAsia News
Executive Summary
Japanese diagnostics maker Osaka-based Wako Pure Chemical Industries launched a new micro total analysis system and two testing agents to detect hepatocellular carcinoma. Priced at ¥8 million, the system is able to use smaller dose samples and conduct faster diagnoses in as little as two minutes. The company aims to achieve ¥10 billion in sales after five years. (Click here for more - Japanese language